Patient Claim Line’s expert medical negligence team are actively acting on for former patients who have have had treatment that was intended to stabilise their vision. Following the eye treatment, patients have alleged that their vision was negatively affected.

Patients were provided injections to improve or stabilise their vision. These injections are known as intravitreal injections, which is where a drug into the eye (more specifically the vitreous body). It is administered through the white part of the eye (sclera). However, our clients have purported that the needle caused damage to their lens’, causing damage to their vision.

An external independent investigator was brought in by New Cross Hospital following reports from a number of patients that their vision had been affected after receiving these injections. The investigator was tasked with understanding what went wrong with the treatment and suggest what could be improved. They also carried out checks to make sure everything was conducted correctly.

According to the hospital, the locum consultant (a doctor brought in to fill the role temporarily) who performed the treatments has been stopped from carrying out this procedure. In addition, the doctor no longer works in the hospital.

We have learnt that from the hospital’s investigation that 38% of the patients who received intravitreal injections showed evidence of lens damage; with some patients suffering damage in both of their eyes. This complication rate is vastly larger than what would usually be expected. Bearing this in mind, Patient Claim Line believes the number of patients impacted by the treatment could potentially be significant and we encourage anyone who has concerns to come forward.